467 related articles for article (PubMed ID: 33658012)
1. FBW7 suppresses ovarian cancer development by targeting the N
Xu F; Li J; Ni M; Cheng J; Zhao H; Wang S; Zhou X; Wu X
Mol Cancer; 2021 Mar; 20(1):45. PubMed ID: 33658012
[TBL] [Abstract][Full Text] [Related]
2. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
[TBL] [Abstract][Full Text] [Related]
3. YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3-mediated m
Chai RC; Chang YZ; Chang X; Pang B; An SY; Zhang KN; Chang YH; Jiang T; Wang YZ
J Hematol Oncol; 2021 Jul; 14(1):109. PubMed ID: 34246306
[TBL] [Abstract][Full Text] [Related]
4. Fbw7 regulates apoptosis in activated B-cell like diffuse large B-cell lymphoma by targeting Stat3 for ubiquitylation and degradation.
Yao S; Xu F; Chen Y; Ge Y; Zhang F; Huang H; Li L; Lin D; Luo X; Xu J; Luo D; Zhu X; Liu Y
J Exp Clin Cancer Res; 2017 Jan; 36(1):10. PubMed ID: 28069035
[TBL] [Abstract][Full Text] [Related]
5. Ehrlichia chaffeensis TRP120-mediated ubiquitination and proteasomal degradation of tumor suppressor FBW7 increases oncoprotein stability and promotes infection.
Wang JY; Zhu B; Patterson LL; Rogan MR; Kibler CE; McBride JW
PLoS Pathog; 2020 Apr; 16(4):e1008541. PubMed ID: 32353058
[TBL] [Abstract][Full Text] [Related]
6. FBW7/GSK3β mediated degradation of IGF2BP2 inhibits IGF2BP2-SLC7A5 positive feedback loop and radioresistance in lung cancer.
Zhou Z; Zhang B; Deng Y; Deng S; Li J; Wei W; Wang Y; Wang J; Feng Z; Che M; Yang X; Meng J; Li Y; Hu Y; Sun Y; Wen L; Huang F; Sheng Y; Wan C; Yang K
J Exp Clin Cancer Res; 2024 Jan; 43(1):34. PubMed ID: 38281999
[TBL] [Abstract][Full Text] [Related]
7. The Tumor Suppressor FBW7 and the Vitamin D Receptor Are Mutual Cofactors in Protein Turnover and Transcriptional Regulation.
Salehi-Tabar R; Memari B; Wong H; Dimitrov V; Rochel N; White JH
Mol Cancer Res; 2019 Mar; 17(3):709-719. PubMed ID: 30606768
[TBL] [Abstract][Full Text] [Related]
8. FBW7 (F-box and WD Repeat Domain-Containing 7) Negatively Regulates Glucose Metabolism by Targeting the c-Myc/TXNIP (Thioredoxin-Binding Protein) Axis in Pancreatic Cancer.
Ji S; Qin Y; Liang C; Huang R; Shi S; Liu J; Jin K; Liang D; Xu W; Zhang B; Liu L; Liu C; Xu J; Ni Q; Chiao PJ; Li M; Yu X
Clin Cancer Res; 2016 Aug; 22(15):3950-60. PubMed ID: 26983463
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-145 Modulates
Yang Z; Li J; Feng G; Gao S; Wang Y; Zhang S; Liu Y; Ye L; Li Y; Zhang X
J Biol Chem; 2017 Mar; 292(9):3614-3623. PubMed ID: 28104805
[No Abstract] [Full Text] [Related]
10. FBW7 suppresses metastasis of colorectal cancer by inhibiting HIF1α/CEACAM5 functional axis.
Li Q; Li Y; Li J; Ma Y; Dai W; Mo S; Xu Y; Li X; Cai S
Int J Biol Sci; 2018; 14(7):726-735. PubMed ID: 29910683
[TBL] [Abstract][Full Text] [Related]
11. FBW7 regulates DNA interstrand cross-link repair by modulating FAAP20 degradation.
Wang J; Jo U; Joo SY; Kim H
Oncotarget; 2016 Jun; 7(24):35724-35740. PubMed ID: 27232758
[TBL] [Abstract][Full Text] [Related]
12. FBW7 loss promotes epithelial-to-mesenchymal transition in non-small cell lung cancer through the stabilization of Snail protein.
Zhang Y; Zhang X; Ye M; Jing P; Xiong J; Han Z; Kong J; Li M; Lai X; Chang N; Zhang J; Zhang J
Cancer Lett; 2018 Apr; 419():75-83. PubMed ID: 29355657
[TBL] [Abstract][Full Text] [Related]
13. Physiological functions of FBW7 in cancer and metabolism.
Shimizu K; Nihira NT; Inuzuka H; Wei W
Cell Signal; 2018 Jun; 46():15-22. PubMed ID: 29474981
[TBL] [Abstract][Full Text] [Related]
14. FBW7 suppresses cell proliferation and G2/M cell cycle transition via promoting γ-catenin K63-linked ubiquitylation.
Li Y; Hu K; Xiao X; Wu W; Yan H; Chen H; Chen Z; Yin D
Biochem Biophys Res Commun; 2018 Mar; 497(2):473-479. PubMed ID: 29408378
[TBL] [Abstract][Full Text] [Related]
15. EglN2 contributes to triple negative breast tumorigenesis by functioning as a substrate for the FBW7 tumor suppressor.
Takada M; Zhuang M; Inuzuka H; Zhang J; Zurlo G; Zhang J; Zhang Q
Oncotarget; 2017 Jan; 8(4):6787-6795. PubMed ID: 28036276
[TBL] [Abstract][Full Text] [Related]
16. Proteasomal degradation of the tumour suppressor FBW7 requires branched ubiquitylation by TRIP12.
Khan OM; Almagro J; Nelson JK; Horswell S; Encheva V; Keyan KS; Clurman BE; Snijders AP; Behrens A
Nat Commun; 2021 Apr; 12(1):2043. PubMed ID: 33824312
[TBL] [Abstract][Full Text] [Related]
17. Regulation of GATA-binding protein 2 levels via ubiquitin-dependent degradation by Fbw7: involvement of cyclin B-cyclin-dependent kinase 1-mediated phosphorylation of THR176 in GATA-binding protein 2.
Nakajima T; Kitagawa K; Ohhata T; Sakai S; Uchida C; Shibata K; Minegishi N; Yumimoto K; Nakayama KI; Masumoto K; Katou F; Niida H; Kitagawa M
J Biol Chem; 2015 Apr; 290(16):10368-81. PubMed ID: 25670854
[TBL] [Abstract][Full Text] [Related]
18. METTL3 facilitates tumor progression via an m
Li T; Hu PS; Zuo Z; Lin JF; Li X; Wu QN; Chen ZH; Zeng ZL; Wang F; Zheng J; Chen D; Li B; Kang TB; Xie D; Lin D; Ju HQ; Xu RH
Mol Cancer; 2019 Jun; 18(1):112. PubMed ID: 31230592
[TBL] [Abstract][Full Text] [Related]
19. PRMT5 enhances tumorigenicity and glycolysis in pancreatic cancer via the FBW7/cMyc axis.
Qin Y; Hu Q; Xu J; Ji S; Dai W; Liu W; Xu W; Sun Q; Zhang Z; Ni Q; Zhang B; Yu X; Xu X
Cell Commun Signal; 2019 Mar; 17(1):30. PubMed ID: 30922330
[TBL] [Abstract][Full Text] [Related]
20. FBW7 is associated with prognosis, inhibits malignancies and enhances temozolomide sensitivity in glioblastoma cells.
Lin J; Ji A; Qiu G; Feng H; Li J; Li S; Zou Y; Cui Y; Song C; He H; Lu Y
Cancer Sci; 2018 Apr; 109(4):1001-1011. PubMed ID: 29427543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
